IL138279A0 - Benzofurylpyrone derivatives and pharmaceutical compositions containing the same - Google Patents
Benzofurylpyrone derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL138279A0 IL138279A0 IL13827999A IL13827999A IL138279A0 IL 138279 A0 IL138279 A0 IL 138279A0 IL 13827999 A IL13827999 A IL 13827999A IL 13827999 A IL13827999 A IL 13827999A IL 138279 A0 IL138279 A0 IL 138279A0
- Authority
- IL
- Israel
- Prior art keywords
- carbon
- benzofurylpyrone
- derivatives
- same
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Luminescent Compositions (AREA)
- Farming Of Fish And Shellfish (AREA)
- External Artificial Organs (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6135698 | 1998-03-12 | ||
| PCT/JP1999/001225 WO1999046262A1 (fr) | 1998-03-12 | 1999-03-12 | Derives de benzofurylpyrone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL138279A0 true IL138279A0 (en) | 2001-10-31 |
Family
ID=13168805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13827999A IL138279A0 (en) | 1998-03-12 | 1999-03-12 | Benzofurylpyrone derivatives and pharmaceutical compositions containing the same |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6589984B1 (fr) |
| EP (1) | EP1063235B1 (fr) |
| JP (1) | JP3922884B2 (fr) |
| KR (1) | KR100595332B1 (fr) |
| CN (1) | CN1170827C (fr) |
| AT (1) | ATE266659T1 (fr) |
| AU (1) | AU756965B2 (fr) |
| BG (1) | BG104761A (fr) |
| BR (1) | BR9908706A (fr) |
| CA (1) | CA2323456A1 (fr) |
| DE (1) | DE69917237T2 (fr) |
| EE (1) | EE200000504A (fr) |
| HR (1) | HRP20000600A2 (fr) |
| HU (1) | HUP0101381A3 (fr) |
| ID (1) | ID27511A (fr) |
| IL (1) | IL138279A0 (fr) |
| IS (1) | IS5617A (fr) |
| NO (1) | NO20004517L (fr) |
| NZ (1) | NZ506802A (fr) |
| PL (1) | PL343419A1 (fr) |
| RU (1) | RU2199536C2 (fr) |
| SK (1) | SK13412000A3 (fr) |
| TR (1) | TR200002642T2 (fr) |
| UA (1) | UA58587C2 (fr) |
| WO (1) | WO1999046262A1 (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU756965B2 (en) * | 1998-03-12 | 2003-01-30 | Microbial Chemistry Research Foundation | Benzofurylpyrone derivatives |
| AU2001288432A1 (en) * | 2000-09-01 | 2002-03-22 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| DE10115408A1 (de) | 2001-03-29 | 2002-10-02 | Bayer Ag | Benzofuran-Derivate |
| CA2473100A1 (fr) * | 2002-02-25 | 2003-08-28 | Kudos Pharmaceuticals Limited | Pyranones utiles comme inhibiteurs de l'atm |
| DE10314610A1 (de) | 2003-04-01 | 2004-11-04 | Aventis Pharma Deutschland Gmbh | Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung |
| EP2061767B1 (fr) | 2006-08-08 | 2014-12-17 | Sanofi | Imidazolidin-2,4-diones arylaminoaryl-alkyl-substituées, procédé de fabrication, médicaments les contenant et leur utilisation |
| EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
| DE102007054497B3 (de) * | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
| FR2929276B1 (fr) * | 2008-04-01 | 2010-04-23 | Servier Lab | Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW201014822A (en) | 2008-07-09 | 2010-04-16 | Sanofi Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
| DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
| US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| WO2012120055A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| WO2012120053A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation |
| WO2012120057A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation |
| WO2012120058A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation |
| WO2012120056A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| WO2012120051A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120050A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| EP2567959B1 (fr) | 2011-09-12 | 2014-04-16 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
| DE102014214016A1 (de) | 2014-07-18 | 2015-11-05 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Leichtbaustruktur und Verfahren zur Herstellung einer Leichtbaustruktur |
| US11433047B2 (en) * | 2015-10-09 | 2022-09-06 | Neurotheryx Canada Ltd. | Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668803A (en) * | 1984-05-10 | 1987-05-26 | Atlantic Richfield Company | Benzafuran derivatives |
| DE4308451A1 (de) | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| US6005103A (en) | 1993-11-19 | 1999-12-21 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
| AU756965B2 (en) * | 1998-03-12 | 2003-01-30 | Microbial Chemistry Research Foundation | Benzofurylpyrone derivatives |
-
1999
- 1999-03-12 AU AU32773/99A patent/AU756965B2/en not_active Ceased
- 1999-03-12 PL PL99343419A patent/PL343419A1/xx not_active Application Discontinuation
- 1999-03-12 US US09/646,005 patent/US6589984B1/en not_active Expired - Fee Related
- 1999-03-12 EP EP99939191A patent/EP1063235B1/fr not_active Expired - Lifetime
- 1999-03-12 ID IDW20001761A patent/ID27511A/id unknown
- 1999-03-12 HU HU0101381A patent/HUP0101381A3/hu unknown
- 1999-03-12 CN CNB99805917XA patent/CN1170827C/zh not_active Expired - Fee Related
- 1999-03-12 KR KR1020007010037A patent/KR100595332B1/ko not_active IP Right Cessation
- 1999-03-12 TR TR2000/02642T patent/TR200002642T2/xx unknown
- 1999-03-12 AT AT99939191T patent/ATE266659T1/de not_active IP Right Cessation
- 1999-03-12 RU RU2000125690/04A patent/RU2199536C2/ru not_active IP Right Cessation
- 1999-03-12 NZ NZ506802A patent/NZ506802A/xx unknown
- 1999-03-12 SK SK1341-2000A patent/SK13412000A3/sk unknown
- 1999-03-12 DE DE69917237T patent/DE69917237T2/de not_active Expired - Fee Related
- 1999-03-12 CA CA002323456A patent/CA2323456A1/fr not_active Abandoned
- 1999-03-12 JP JP2000535641A patent/JP3922884B2/ja not_active Expired - Fee Related
- 1999-03-12 BR BR9908706-5A patent/BR9908706A/pt not_active IP Right Cessation
- 1999-03-12 WO PCT/JP1999/001225 patent/WO1999046262A1/fr not_active Application Discontinuation
- 1999-03-12 EE EEP200000504A patent/EE200000504A/xx unknown
- 1999-03-12 IL IL13827999A patent/IL138279A0/xx unknown
- 1999-12-03 UA UA2000105676A patent/UA58587C2/uk unknown
-
2000
- 2000-09-08 IS IS5617A patent/IS5617A/is unknown
- 2000-09-11 NO NO20004517A patent/NO20004517L/no unknown
- 2000-09-12 BG BG104761A patent/BG104761A/xx unknown
- 2000-09-12 HR HR20000600A patent/HRP20000600A2/hr not_active Application Discontinuation
-
2003
- 2003-05-12 US US10/435,746 patent/US20030186976A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1063235A1 (fr) | 2000-12-27 |
| US6589984B1 (en) | 2003-07-08 |
| NO20004517D0 (no) | 2000-09-11 |
| CA2323456A1 (fr) | 1999-09-16 |
| PL343419A1 (en) | 2001-08-13 |
| AU3277399A (en) | 1999-09-27 |
| EP1063235B1 (fr) | 2004-05-12 |
| ID27511A (id) | 2001-04-12 |
| UA58587C2 (uk) | 2003-08-15 |
| CN1170827C (zh) | 2004-10-13 |
| RU2199536C2 (ru) | 2003-02-27 |
| EE200000504A (et) | 2002-02-15 |
| AU756965B2 (en) | 2003-01-30 |
| BG104761A (en) | 2001-08-31 |
| IS5617A (is) | 2000-09-08 |
| CN1299359A (zh) | 2001-06-13 |
| HUP0101381A3 (en) | 2002-06-28 |
| DE69917237D1 (de) | 2004-06-17 |
| EP1063235A4 (fr) | 2003-01-07 |
| BR9908706A (pt) | 2000-11-21 |
| HUP0101381A2 (hu) | 2002-05-29 |
| JP3922884B2 (ja) | 2007-05-30 |
| TR200002642T2 (tr) | 2001-01-22 |
| US20030186976A1 (en) | 2003-10-02 |
| DE69917237T2 (de) | 2005-05-04 |
| NO20004517L (no) | 2000-09-11 |
| SK13412000A3 (sk) | 2001-04-09 |
| KR100595332B1 (ko) | 2006-07-03 |
| ATE266659T1 (de) | 2004-05-15 |
| HRP20000600A2 (en) | 2001-06-30 |
| WO1999046262A1 (fr) | 1999-09-16 |
| NZ506802A (en) | 2002-11-26 |
| KR20010041776A (ko) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL138279A0 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing the same | |
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| AU583439B2 (en) | Prodrugs of rapamycin | |
| CA2316902A1 (fr) | Derives alpha-aminoamides utiles en tant qu'agents analgesiques | |
| DE69223827D1 (de) | Glycyrrheticsäurederivate | |
| ATE109770T1 (de) | Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten. | |
| DK0488513T3 (da) | Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen | |
| PH30229A (en) | Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility | |
| DE3060888D1 (en) | 5(10- 9)abeo-ergoline derivatives, their preparation, and therapeutic compositions containing them | |
| EP0259972A3 (en) | Heterocyclic propene amide derivatives, processes for their preparation and their use as pharmaceuticals | |
| NZ511572A (en) | Eudesmadienolide derivatives useful as glucose and lipid lowering compounds | |
| NZ220294A (en) | Heteropolycyclic aromatic amines and pharmaceutical compositions thereof | |
| ATE112682T1 (de) | Isocarbacyclinderivate enthaltende antidiabetika. | |
| TW353071B (en) | Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions | |
| AU7547194A (en) | Composition for remedying drug dependence |